Chemoinformatics approach to design and develop vanillin analogs as COX-1 inhibitor

BACKGROUND: Coronary Heart Disease (CHD), commonly known as the silent killer, impacted the severity of COVID-19 patients during the pandemic era. Thrombosis or blood clots create the buildup of plaque on the coronary artery walls of the heart, which leads to coronary heart disease. Cyclooxygenase 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Norhayati, Ekowati, Juni, Diyah, Nuzul Wahyuning, Tejo, Bimo Ario, Ahmed, Samar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365673/
https://www.ncbi.nlm.nih.gov/pubmed/37492541
http://dx.doi.org/10.4081/jphia.2023.2517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365673/
https://www.ncbi.nlm.nih.gov/pubmed/37492541
http://dx.doi.org/10.4081/jphia.2023.2517

Ejemplares similares